The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 09, 2024
Filed:
Nov. 12, 2021
Applicants:
Suzhou Suncadia Biopharmaceuticals Co., Ltd., Jiangsu, CN;
Jiangsu Hengrui Medicine Co., Ltd., Jiangsu, CN;
Shanghai Hengrui Pharmaceutical Co., Ltd., Shanghai, CN;
Inventors:
Xing Sun, Jiangsu, CN;
Guoqing Cao, Jiangsu, CN;
Changyong Yang, Jiangsu, CN;
Lianshan Zhang, Jiangsu, CN;
Yong Guo, Jiangsu, CN;
Assignees:
Suzhou Suncadia Biopharmaceuticals Co., Ltd., Suzhou, CN;
Jiangsu Hengrui Medicine Co., Ltd., Lianyungang, CN;
Shanghai Hengrui Pharmaceutical Co., Ltd., Minhang District, CN;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/28 (2006.01); A61P 35/00 (2006.01); A61K 9/00 (2006.01); A61K 31/444 (2006.01); A61K 39/395 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C07K 16/2818 (2013.01); A61K 9/0053 (2013.01); A61K 31/444 (2013.01); A61K 39/3955 (2013.01); A61P 35/00 (2018.01); A61K 2039/505 (2013.01); A61K 2039/54 (2013.01); A61K 2039/545 (2013.01); C07K 2317/24 (2013.01); C07K 2317/565 (2013.01);
Abstract
Disclosed is the use of a combination of an anti-PD-1 antibody and a VEGFR inhibitor in the preparation of a drug for treating cancers.